- Atlas
- Medicine & Health
- Molecular Imaging
Molecular Imaging
Molecular imaging is the branch of medical imaging that pictures molecules rather than anatomy.
13 frameworks, from 1910 to today · Medical Imaging · Medicine & Health
- Tracer Principle 1910-Present
- Scintigraphy 1958-1990
- Emission computed tomography 1965-Present
- Positron Emission Tomography 1975-Present
- Quantitative Molecular Imaging 1975-Present
- Metabolic Imaging with FDG 1976-Present
- Magnetic Resonance Spectroscopy and Spectroscopic Imaging 1983-Present
- Receptor-Targeted Imaging 1983-Present
- Fluorescence imaging 1990-Present
- Targeted Ultrasound Molecular Imaging 1995-Present
- Multimodal Hybrid Imaging 2000-Present
- Hyperpolarized carbon-13 MRI 2003-Present
- Total-Body PET 2018-Present
Overview
Molecular imaging is the branch of medical imaging that pictures molecules rather than anatomy1. Where a chest X-ray shows the shape of the lungs and a CT scan shows the density of tissue, molecular imaging shows where a particular chemical process is happening: where glucose is being consumed, where a receptor is being occupied, where an enzyme is active, where a gene is being expressed. Its practitioners make a probe—usually a molecule tagged with a signal-emitting label—introduce it into the body, and detect the signal from outside1. The stakes are large. Molecular imaging can reveal a tumour's metabolism before it has changed shape, show whether a drug is reaching its target, distinguish a living from a dead patch of heart muscle, or watch a neurotransmitter system at work in a living brain. The field's history is the story of learning to make probes that are specific, signals that are detectable, and measurements that are quantitative.
The Tracer Principle and the Birth of Nuclear Medicine
The founding idea is the tracer principle: if you introduce a tiny quantity of a substance into a living system and follow where it goes, you can study the system's behaviour without disturbing it2. The Hungarian chemist George de Hevesy proposed this in the 1910s and demonstrated it in 1923 by feeding radioactive lead to rats and tracking its distribution. Hevesy's insight was that radioactivity makes a substance visible in amounts far too small to affect the biology—a few atoms can be detected. For this work he received the Nobel Prize in Chemistry in 1943.
The principle became clinical in the mid-twentieth century. In 1946, the physicists and physicians working in the United States developed radioiodine as a tracer for thyroid function, and by the 1950s iodine-131 was being used both to diagnose and to treat thyroid disease. The gamma camera, built by Hal Anger in the late 1950s, made it possible to image the distribution of a radionuclide in a patient without moving a detector across the body point by point. Anger's camera used a large scintillation crystal and a collimator to produce a planar image—a two-dimensional picture of where the tracer had accumulated. This was planar scintigraphy, and it became the workhorse of nuclear medicine: bone scans, lung perfusion scans, and thyroid scans all rested on it.
Tomography: Seeing in Three Dimensions
Planar images collapse depth. A hot spot in front of the body and one behind it look the same. The solution was emission tomography: reconstructing a three-dimensional distribution from many projections3. Single-photon emission computed tomography (SPECT), developed in the 1960s and 1970s, rotated a gamma camera around the patient and used reconstruction algorithms—borrowed from the mathematics of CT—to build slices. SPECT made it possible to localize tracer uptake in three dimensions and became routine for cardiac perfusion imaging and brain studies.
Positron emission tomography (PET) took a different route1. Certain radionuclides decay by emitting a positron, which annihilates with an electron to produce two gamma rays flying apart at almost exactly 180 degrees1. Detecting these coincident pairs in a ring of detectors localizes the annihilation event along a line, and reconstruction builds the distribution. The physics was understood in the 1950s; the first practical PET scanners were built in the 1970s, notably by Michael Phelps and colleagues at Washington University and later UCLA. PET's advantage was sensitivity and the ability to label biologically important atoms—carbon-11, nitrogen-13, oxygen-15—directly. Its disadvantage was cost and the need for a nearby cyclotron to make short-lived isotopes1.
FDG and Metabolic Imaging
The turning point that brought PET into mainstream medicine was fluorine-18 fluorodeoxyglucose (FDG)4. FDG is a glucose analogue: cells take it up as they would glucose, but it is trapped inside the cell after the first step of metabolism. Because many cancers consume glucose avidly, FDG accumulates in tumours. The compound was developed in the 1970s, building on work by Louis Sokoloff and colleagues on deoxyglucose autoradiography in animals. By the 1990s, FDG-PET was being used to stage cancer, and its ability to distinguish malignant from benign tissue changed oncology practice. The same tracer mapped brain glucose metabolism and became a tool in neuroscience and, later, in dementia diagnosis.
Receptor-Targeted and Beyond
FDG measures metabolism, but the field's ambition was receptor-targeted imaging: probes designed to bind a specific molecular target. The development of radiolabeled receptor ligands in the 1980s and 1990s—for dopamine receptors, for somatostatin receptors in neuroendocrine tumours—showed that imaging could report on molecular identity, not just metabolic rate. This lineage continues today in PSMA-targeted PET for prostate cancer and in a growing family of peptide and antibody probes.
Quantitative Molecular Imaging
A picture is not a measurement. Quantitative molecular imaging asks how much tracer is in a region, not just whether it is visible1. The mathematics of tracer kinetics—compartment models describing how a tracer moves between blood and tissue—was developed from the 1970s onward, allowing PET to estimate rates of blood flow, metabolism, and receptor binding. Quantification made molecular imaging a tool for drug development and for measuring treatment response, not only for diagnosis.
Magnetic Resonance: Spectroscopy and Hyperpolarization
Molecular imaging is not only nuclear. Magnetic resonance spectroscopy (MRS) uses the same physics as MRI—the behaviour of atomic nuclei in a magnetic field—but reads the chemical shift of signals to identify molecules such as choline, creatine, and lactate in tissue. MRS and spectroscopic imaging, developed from the 1980s, gave a non-radioactive way to probe metabolism, though with far lower sensitivity than PET.
Hyperpolarized MRI addressed that sensitivity gap. In the early 2000s, researchers learned to hyperpolarize carbon-13—aligning its nuclear spins far beyond thermal equilibrium—so that a labelled metabolite such as pyruvate could be detected in real time as it was converted in tissue. This made it possible to watch metabolic fluxes in a living body without ionizing radiation, a capability still being developed clinically.
Optical and Ultrasound Approaches
Optical fluorescence imaging uses light-emitting probes—fluorescent dyes and proteins—to image molecular events5. Its penetration depth is limited, so it has been most powerful in small-animal research and in surgery, where fluorescent agents can help a surgeon see tumour margins. Targeted ultrasound microbubbles—gas-filled spheres coated with ligands that bind to specific molecules on blood vessel walls—extend molecular imaging to ultrasound, exploiting the strong signal that microbubbles produce when they oscillate in a sound field.
Hybrid Imaging and Total-Body PET
The most consequential clinical development of recent decades was multimodal hybrid imaging: combining two modalities in one scanner so that molecular signal and anatomy are registered in the same session. PET/CT, introduced around 2000, and later PET/MRI, let clinicians see exactly where a tracer hot spot sits in the body. Hybrid imaging became the standard for oncologic PET.
Most recently, total-body PET scanners, built in the 2010s and entering clinical use in the 2020s, detect nearly the whole body at once with greatly increased sensitivity. This allows lower doses, faster scans, and dynamic imaging of tracer distribution throughout the body—opening questions about how molecular processes are coupled across organs.
The Present
Molecular imaging today is a family of approaches rather than a single technique. Radionuclide imaging—PET and SPECT—remains the clinical core, with FDG and a growing set of targeted tracers. MRI-based methods, including hyperpolarized agents and spectroscopy, offer non-radioactive alternatives with different trade-offs. Optical and ultrasound molecular imaging are strongest in research and surgical settings. The open questions are familiar in shape: how to make probes more specific, how to quantify reliably across scanners and sites, how to bring the sensitivity of physics to bear on the molecular events that matter clinically, and how to translate the remarkable capabilities demonstrated in research into routine care.
References
- Molecular imaging (introduction, Positron emission tomography, Overview), Wikipedia
- American Board of Nuclear Medicine, Wikipedia
- Emission computed tomography, Wikipedia
- Positron emission tomography (History), Wikipedia
- Fluorescence imaging, Wikipedia
The frameworks of Molecular Imaging
Each framework is a way of working the field has used: when it held, and the question it answers.
- 1910-Present
Tracer Principle
How can we track a substance without altering its natural behavior?
- 1958-1990
Scintigraphy
How can we create a 2D picture of where a substance is located?
- 1965-Present
Emission computed tomography
How can we reconstruct a 3D map from multiple 2D views?
- 1975-Present
Positron Emission Tomography
How can we map molecular activity using particle emission?
- 1975-Present
Quantitative Molecular Imaging
How much of a substance is in a specific area?
- 1976-Present
Metabolic Imaging with FDG
How can we image a specific biological process using a labeled molecule?
- 1983-Present
Magnetic Resonance Spectroscopy and Spectroscopic Imaging
How can we identify molecules based on their atomic properties?
- 1983-Present
Receptor-Targeted Imaging
How can we design probes to find specific molecular targets?
- 1990-Present
Fluorescence imaging
How can we use light to visualize molecular events?
- 1995-Present
Targeted Ultrasound Molecular Imaging
How can we use sound waves to detect molecular binding?
- 2000-Present
Multimodal Hybrid Imaging
How can we combine different types of imaging data for a complete picture?
- 2003-Present
Hyperpolarized carbon-13 MRI
How can we boost the signal from naturally occurring atomic spins?
- 2018-Present
Total-Body PET
How can we image the entire body simultaneously with high sensitivity?
How the ideas connect
Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.
Metabolic Imaging with FDG grew out of Tracer Principle
FDG-PET is a direct application of the tracer principle, using a biologically relevant molecule (glucose analogue) labeled for detection.
Carried by Louis Sokoloff.
Scintigraphy grew out of Tracer Principle
The tracer principle provided the foundational concept of using a labeled substance to track biological processes, which was directly applied to the development of planar imaging using gamma cameras.
Carried by Hal Anger.
Quantitative Molecular Imaging grew out of Tracer Principle
The concept of tracking a substance (tracer principle) was extended from simple visualization to the mathematical modeling of its concentration and movement within tissues.
Emission computed tomography grew out of Scintigraphy
The need to overcome the limitations of planar imaging led to the development of emission tomography, which used reconstruction algorithms based on projection data from gamma cameras.
Multimodal Hybrid Imaging influenced by Positron Emission Tomography
The development of PET scanners provided the primary molecular signal component that was subsequently integrated with anatomical data.
Hyperpolarized carbon-13 MRI grew out of Magnetic Resonance Spectroscopy and Spectroscopic Imaging
Hyperpolarization is a technique that enhances the signal detection capability inherent in magnetic resonance spectroscopy.
Receptor-Targeted Imaging influenced by Quantitative Molecular Imaging
Targeted imaging requires quantitative assessment of binding affinity and occupancy, building upon the kinetic modeling established for tracer uptake.
Beyond the field
Where Molecular Imaging's ideas came from in other fields, and what they led to there: the strongest 12 of 59 links.
Tracer Principle influenced by Radioactivity and Nuclear Spectroscopy in Nuclear Physics
The tracer principle grew directly from the new science of radioactivity: Georg von Hevesy used radioactive lead and bismuth as indicators to follow their fate in plants and animals, founding the idea of a radioactive tracer. Without the discovery and handling of radioisotopes the principle could not exist.
Carried by Georg von Hevesy.
Tracer Principle influenced Nuclear Medicine Physics in Imaging Physics
The tracer principle, introduced by Hevesy in 1913 and developed through the 1920s, is the conceptual foundation of nuclear medicine: a radioactive substance traces a physiological pathway without perturbing it. Nuclear medicine physics formalised the detection and quantification of such tracers.
Carried by George de Hevesy.
Tracer Principle influenced Autoradiography and Metabolic Tracer Mapping in Neuroimaging
The tracer principle, established by Hevesy's use of radioactive indicators, is the direct basis of autoradiographic metabolic mapping: a labeled substance traces its own distribution and fate in tissue.
Carried by George de Hevesy.
Tracer Principle influenced Tracer kinetic modelling in Quantitative Imaging
Tracer kinetic modelling applies the tracer principle, the use of a labelled substance to follow a physiological pathway, to derive rate constants from dynamic imaging data. The compartmental analysis of tracer behaviour descends directly from that principle.
Tracer Principle influenced Isotope Tracer and Turnover Paradigm in Nutritional Biochemistry
The tracer principle, established by Hevesy's use of radioactive indicators to follow substances through living systems, is the direct basis of the isotope tracer and turnover paradigm; stable and radioactive isotope tracers applied to nutrients are that principle in nutritional biochemistry.
Carried by George de Hevesy.
Emission computed tomography influenced Positron Emission Tomography in Neuroimaging
PET developed out of earlier emission computed tomography using single-photon radionuclides; the move to positron emitters and coincidence detection built on that tomographic framework.
Carried by David Kuhl; Michael Phelps.
Positron Emission Tomography influenced by Tomographic reconstruction in Imaging Physics
PET images are produced by tomographic reconstruction algorithms, notably filtered back-projection and later iterative methods, developed for computed tomography and adapted to coincidence data. Without reconstruction from projections PET could not form an image.
Quantitative Molecular Imaging led to Quantitative imaging biomarker standardization (QIBA model) in Quantitative Imaging
QIBA-style biomarker standardization grew directly out of quantitative molecular imaging's effort to make imaging measures reproducible across sites and scanners. It formalizes that field's quantitative aims into consensus profiles.
Metabolic Imaging with FDG influenced by Autoradiography and Metabolic Tracer Mapping in Neuroimaging
FDG imaging directly translated the 2-deoxyglucose autoradiographic method for mapping local glucose metabolism in animals to the living human with a positron-labelled analogue. The Sokoloff method supplied the concept and the kinetic model.
Carried by Louis Sokoloff.
Magnetic Resonance Spectroscopy and Spectroscopic Imaging grew out of Nuclear magnetic resonance spectroscopy in Spectroscopy
In vivo magnetic resonance spectroscopy is nuclear magnetic resonance spectroscopy applied to living tissue, keeping the chemical-shift readout of metabolite resonances while adding localization. The later field is a direct extension of the earlier spectroscopic method.
Magnetic Resonance Spectroscopy and Spectroscopic Imaging influenced by Two-dimensional and multidimensional NMR in Spectroscopy
Multidimensional NMR methods developed in the 1970s, notably two-dimensional correlation and J-resolved spectroscopy, supplied the pulse sequences and spatial-encoding concepts that spectroscopic imaging adapted to map metabolites in vivo. The chemical-shift imaging approach grew directly from these NMR techniques.
Carried by Richard R. Ernst.
Receptor-Targeted Imaging influenced by Receptor theory in Drug Discovery
Receptor theory supplied the concept of specific high-affinity ligand binding to receptors that receptor-targeted imaging exploits to design tracers. The imaging approach is the application of receptor-binding principles to visualize receptor distribution in vivo.

Molecular Imaging is a planet in Nousfarer
Its city has a tower for each of these 13 frameworks. Land, walk in, and climb one concept at a time.
Land on Molecular ImagingRelated fields
Fields its ideas are linked to
- Neuroimaging 15 links
- Medical Imaging 14 links
- Imaging Physics 13 links
- Quantitative Imaging 7 links
- Spectroscopy 2 links
- Cell Biology 1 link
- Analytical Chemistry 1 link
- Medicinal Chemistry 1 link
- Drug Discovery 1 link
- Pharmacology 1 link
- Nutritional Biochemistry 1 link
- Atomic Molecular Physics 1 link
More in Medical Imaging
- Diagnostic Radiology
- Image Reconstruction
- Imaging Informatics
- Imaging Physics
- Interventional Radiology
- Medical Image Analysis
- Medical Imaging
- Nuclear Medicine
- Quantitative Imaging
See where Molecular Imaging sits on the Map of Human Knowledge